{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:03:41Z","timestamp":1789513421442,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370096 and 82003622"],"award-info":[{"award-number":["32370096 and 82003622"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012620","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202312092 and tsqn202312041"],"award-info":[{"award-number":["tsqn202312092 and tsqn202312041"]}],"id":[{"id":"10.13039\/100012620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["2023HWQY-068"],"award-info":[{"award-number":["2023HWQY-068"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76647-5","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:45:44Z","timestamp":1786956344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineered bacteria as exogenous organelle mimics restore PTEN and p53 tumor suppressor functions for cancer therapy"],"prefix":"10.1038","volume":"17","author":[{"given":"Shijie","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runchang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1702-6335","authenticated-orcid":false,"given":"Youming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5120-4674","authenticated-orcid":false,"given":"Jun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2278-4622","authenticated-orcid":false,"given":"Ruijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3959-9790","authenticated-orcid":false,"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"76647_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42156-y","volume":"14","author":"LM Blair","year":"2023","unstructured":"Blair, L. M. et al. Oncogenic context shapes the fitness landscape of tumor suppression. Nat. Commun. 14, 6422 (2023).","journal-title":"Nat. Commun."},{"key":"76647_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41576-023-00663-0","volume":"25","author":"K Krupina","year":"2024","unstructured":"Krupina, K., Goginashvili, A. & Cleveland, D. W. Scrambling the genome in cancer: causes and consequences of complex chromosome rearrangements. Nat. Rev. Genet 25, 196\u2013210 (2024).","journal-title":"Nat. Rev. Genet"},{"key":"76647_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41420-023-01775-6","volume":"9","author":"H Qian","year":"2023","unstructured":"Qian, H. et al. Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets. Cell Death Discov. 9, 470 (2023).","journal-title":"Cell Death Discov."},{"key":"76647_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu, X. et al. Cancer epigenetics: from laboratory studies and clinical trials to precision medicine. Cell Death Discov. 10, 28 (2024).","journal-title":"Cell Death Discov."},{"key":"76647_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf6724","volume":"15","author":"W Shi","year":"2023","unstructured":"Shi, W. et al. Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies. Sci. Transl. Med 15, eadf6724 (2023).","journal-title":"Sci. Transl. Med"},{"key":"76647_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2006.11.042","volume":"128","author":"WH Shen","year":"2007","unstructured":"Shen, W. H. et al. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128, 157\u2013170 (2007).","journal-title":"Cell"},{"key":"76647_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29227-2","volume":"13","author":"IG Serebriiskii","year":"2022","unstructured":"Serebriiskii, I. G. et al. Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers. Nat. Commun. 13, 1618 (2022).","journal-title":"Nat. Commun."},{"key":"76647_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06657-y","volume":"15","author":"Y Li","year":"2024","unstructured":"Li, Y., Ma, R. & Hao, X. Therapeutic role of PTEN in tissue regeneration for management of neurological disorders: stem cell behaviors to an in-depth review. Cell Death Dis. 15, 268 (2024).","journal-title":"Cell Death Dis."},{"key":"76647_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27833-0","volume":"13","author":"Z Qi","year":"2022","unstructured":"Qi, Z. et al. Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3K\u03b1\/\u03b2\/\u03b4 treatment. Nat. Commun. 13, 182 (2022).","journal-title":"Nat. Commun."},{"key":"76647_CR10","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1016\/j.devcel.2024.08.003","volume":"59","author":"C Zhang","year":"2024","unstructured":"Zhang, C. et al. Secreted PTEN binds PLXDC2 on macrophages to drive antitumor immunity and tumor suppression. Dev. Cell 59, 3072\u20133088.e3078 (2024).","journal-title":"Dev. Cell"},{"key":"76647_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-023-05940-w","volume":"617","author":"JS Bergholz","year":"2023","unstructured":"Bergholz, J. S. et al. PI3K\u03b2 controls immune evasion in PTEN-deficient breast tumours. Nature 617, 139\u2013146 (2023).","journal-title":"Nature"},{"key":"76647_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang, H., Guo, M., Wei, H. & Chen, Y. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct. Target Ther. 8, 92 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"76647_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41586-023-06253-8","volume":"619","author":"AM Kaiser","year":"2023","unstructured":"Kaiser, A. M. et al. p53 governs an AT1 differentiation programme in lung cancer suppression. Nature 619, 851\u2013859 (2023).","journal-title":"Nature"},{"key":"76647_CR14","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41556-022-00949-1","volume":"24","author":"M Chen","year":"2022","unstructured":"Chen, M. et al. A p53-phosphoinositide signalosome regulates nuclear AKT activation. Nat. Cell Biol. 24, 1099\u20131113 (2022).","journal-title":"Nat. Cell Biol."},{"key":"76647_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1535-6108(03)00021-7","volume":"3","author":"DJ Freeman","year":"2003","unstructured":"Freeman, D. J. et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 3, 117\u2013130 (2003).","journal-title":"Cancer Cell"},{"key":"76647_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","volume":"10","author":"S Singh","year":"2025","unstructured":"Singh, S. et al. Glioblastoma at the crossroads: current understanding and future therapeutic horizons. Signal Transduct. Target Ther. 10, 213 (2025).","journal-title":"Signal Transduct. Target Ther."},{"key":"76647_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adh4475","volume":"17","author":"W Treekitkarnmongkol","year":"2024","unstructured":"Treekitkarnmongkol, W. et al. eEF1A2 promotes PTEN-GSK3\u03b2-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancer. Sci. Signal 17, eadh4475 (2024).","journal-title":"Sci. Signal"},{"key":"76647_CR18","volume":"11","author":"Y Kim","year":"2024","unstructured":"Kim, Y. et al. Design of PD-L1-targeted lipid nanoparticles to turn on PTEN for efficient cancer therapy. Adv. Sci. (Weinh.) 11, e2309917 (2024).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"76647_CR19","volume":"10","author":"R Navaridas","year":"2023","unstructured":"Navaridas, R. et al. In vivo intra-uterine delivery of TAT-fused Cre recombinase and CRISPR\/Cas9 editing system in mice unveil histopathology of Pten\/p53-deficient endometrial cancers. Adv. Sci. (Weinh.) 10, e2303134 (2023).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"76647_CR20","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.add9667","volume":"378","author":"CR Gurbatri","year":"2022","unstructured":"Gurbatri, C. R., Arpaia, N. & Danino, T. Engineering bacteria as interactive cancer therapies. Science 378, 858\u2013864 (2022).","journal-title":"Science"},{"key":"76647_CR21","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1126\/science.adf3974","volume":"381","author":"RM Cooper","year":"2023","unstructured":"Cooper, R. M. et al. Engineered bacteria detect tumor DNA. Science 381, 682\u2013686 (2023).","journal-title":"Science"},{"key":"76647_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/2417","volume":"20","author":"Y Zhang","year":"1998","unstructured":"Zhang, Y., Buchholz, F., Muyrers, J. P. & Stewart, A. F. A new logic for DNA engineering using recombination in Escherichia coli. Nat. Genet 20, 123\u2013128 (1998).","journal-title":"Nat. Genet"},{"key":"76647_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123848","volume":"328","author":"Z Liu","year":"2026","unstructured":"Liu, Z. et al. Chemo-immunotherapeutic potential of Lactobacillus rhamnosus GG and its bioengineering for cancer therapy. Biomaterials 328, 123848 (2026).","journal-title":"Biomaterials"},{"key":"76647_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41571-024-00908-9","volume":"21","author":"SY Kwon","year":"2024","unstructured":"Kwon, S. Y., Thi-Thu Ngo, H., Son, J., Hong, Y. & Min, J. J. Exploiting bacteria for cancer immunotherapy. Nat. Rev. Clin. Oncol. 21, 569\u2013589 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"76647_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101788","volume":"32","author":"Q Guan","year":"2025","unstructured":"Guan, Q. et al. Biocompatible cloaking of bacteria for effective tumor imaging and therapy. Mater. Today Bio. 32, 101788 (2025).","journal-title":"Mater. Today Bio"},{"key":"76647_CR26","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/s41587-022-01244-y","volume":"40","author":"T Harimoto","year":"2022","unstructured":"Harimoto, T. et al. A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nat. Biotechnol. 40, 1259\u20131269 (2022).","journal-title":"Nat. Biotechnol."},{"key":"76647_CR27","first-page":"12","volume":"32","author":"Z Lin","year":"2024","unstructured":"Lin, Z. et al. In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity. Bioact. Mater. 32, 12\u201327 (2024).","journal-title":"Bioact. Mater."},{"key":"76647_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12289","volume":"11","author":"F Meng","year":"2022","unstructured":"Meng, F. et al. Biosynthetic neoantigen displayed on bacteria derived vesicles elicit systemic antitumour immunity. J. Extracell. Vesicles 11, 12289 (2022).","journal-title":"J. Extracell. Vesicles"},{"key":"76647_CR29","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41587-022-01581-y","volume":"41","author":"RC Hurt","year":"2023","unstructured":"Hurt, R. C. et al. Genomically mined acoustic reporter genes for real-time in vivo monitoring of tumors and tumor-homing bacteria. Nat. Biotechnol. 41, 919\u2013931 (2023).","journal-title":"Nat. Biotechnol."},{"key":"76647_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc9436","volume":"9","author":"TM Savage","year":"2023","unstructured":"Savage, T. M. et al. Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity. Sci. Adv. 9, eadc9436 (2023).","journal-title":"Sci. Adv."},{"key":"76647_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.engmic.2023.100097","volume":"3","author":"R Li","year":"2023","unstructured":"Li, R., Li, A., Zhang, Y. & Fu, J. The emerging role of recombineering in microbiology. Eng. Microbiol 3, 100097 (2023).","journal-title":"Eng. Microbiol"},{"key":"76647_CR32","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1021\/acs.accounts.5c00271","volume":"58","author":"M Chen","year":"2025","unstructured":"Chen, M. & Liu, J. Regulating bacteria-host interactions for disease intervention by covalent conjugation of bacterial surface. Acc. Chem. Res. 58, 2110\u20132123 (2025).","journal-title":"Acc. Chem. Res"},{"key":"76647_CR33","doi-asserted-by":"publisher","unstructured":"Zhang, Y., Muyrers, J. P., Rientjes, J. & Stewart, A. F. Phage annealing proteins promote oligonucleotide-directed mutagenesis in Escherichia coli and mouse ES cells. BMC Mol. Biol. https:\/\/doi.org\/10.1186\/1471-2199-4-1 (2003).","DOI":"10.1186\/1471-2199-4-1"},{"key":"76647_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","volume":"20","author":"JF Toso","year":"2002","unstructured":"Toso, J. F. et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J. Clin. Oncol. 20, 142\u2013152 (2002).","journal-title":"J. Clin. Oncol."},{"key":"76647_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26367-9","volume":"12","author":"V Raman","year":"2021","unstructured":"Raman, V. et al. Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases. Nat. Commun. 12, 6116 (2021).","journal-title":"Nat. Commun."},{"key":"76647_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34036-8","volume":"13","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Enhancing Gasdermin-induced tumor pyroptosis through preventing ESCRT-dependent cell membrane repair augments antitumor immune response. Nat. Commun. 13, 6321 (2022).","journal-title":"Nat. Commun."},{"key":"76647_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41392-023-01364-0","volume":"8","author":"L Liu","year":"2023","unstructured":"Liu, L. et al. A bacteria-based system expressing anti-TNF-\u03b1 nanobody for enhanced cancer immunotherapy. Signal Transduct. Target Ther. 8, 134 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"76647_CR38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2202719119","volume":"119","author":"SG Ahmed","year":"2022","unstructured":"Ahmed, S. G. et al. Intratumoral injection of schwannoma with attenuated Salmonella typhimurium induces antitumor immunity and controls tumor growth. Proc. Natl. Acad. Sci. USA. 119, e2202719119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76647_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nature18930","volume":"536","author":"MO Din","year":"2016","unstructured":"Din, M. O. et al. Synchronized cycles of bacterial lysis for in vivo delivery. Nature 536, 81\u201385 (2016).","journal-title":"Nature"},{"key":"76647_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00599-w","volume":"8","author":"AS Hassan","year":"2023","unstructured":"Hassan, A. S. et al. Salmonella Typhimurium expressing chromosomally integrated Schistosoma mansoni Cathepsin B protects against schistosomiasis in mice. NPJ Vaccines 8, 27 (2023).","journal-title":"NPJ Vaccines"},{"key":"76647_CR41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature24624","volume":"551","author":"M Whiteley","year":"2017","unstructured":"Whiteley, M., Diggle, S. P. & Greenberg, E. P. Progress in and promise of bacterial quorum sensing research. Nature 551, 313\u2013320 (2017).","journal-title":"Nature"},{"key":"76647_CR42","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41419-025-07770-2","volume":"16","author":"G Tang","year":"2025","unstructured":"Tang, G. et al. Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53-independent pyroptotic mechanism via ROS\/p-p38\/NOXA\/caspase-3\/GSDME axis. Cell Death Dis. 16, 452 (2025).","journal-title":"Cell Death Dis."},{"key":"76647_CR43","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/molecules30010186","volume":"30","author":"R Lama","year":"2025","unstructured":"Lama, R. et al. Novel inhibitors for MDM2-MDM4 E3 ligase potently induce p53-Indepedent apoptosis in drug-resistant leukemic cells. Molecules 30, 186 (2025).","journal-title":"Molecules"},{"key":"76647_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1508421","volume":"16","author":"M Lu","year":"2025","unstructured":"Lu, M. et al. MDM2 inhibitor induces apoptosis in colon cancer cells through activation of the CHOP-DR5 pathway, independent of p53 phenotype. Front. Pharmacol. 16, 1508421 (2025).","journal-title":"Front. Pharmacol."},{"key":"76647_CR45","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.cell.2024.03.006","volume":"187","author":"LR Kong","year":"2024","unstructured":"Kong, L. R. et al. A glycolytic metabolite bypasses \u201ctwo-hit\u201d tumor suppression by BRCA2. Cell 187, 2269\u20132287.e2216 (2024).","journal-title":"Cell"},{"key":"76647_CR46","doi-asserted-by":"publisher","unstructured":"Yang, Z., Sun, J. K., Lee, M. M. & Chan, M. K. Restoration of p53 activity via intracellular protein delivery sensitizes triple negative breast cancer to anti-PD-1 immunotherapy. J. Immunother. Cancer https:\/\/doi.org\/10.1136\/jitc-2022-005068 (2022).","DOI":"10.1136\/jitc-2022-005068"},{"key":"76647_CR47","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41551-018-0331-x","volume":"2","author":"MA Islam","year":"2018","unstructured":"Islam, M. A. et al. Author correction: restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nat. Biomed. Eng. 2, 968 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"76647_CR48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41586-023-05870-7","volume":"616","author":"J Kreitz","year":"2023","unstructured":"Kreitz, J. et al. Programmable protein delivery with a bacterial contractile injection system. Nature 616, 357\u2013364 (2023).","journal-title":"Nature"},{"key":"76647_CR49","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41587-024-02470-2","volume":"43","author":"H Kim","year":"2025","unstructured":"Kim, H. et al. Lipid nanoparticle-mediated mRNA delivery to CD34(+) cells in rhesus monkeys. Nat. Biotechnol. 43, 1813\u20131820 (2025).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76647-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76647-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76647-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:34:52Z","timestamp":1789511692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76647-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76647"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76647-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9848"}}